Sentences with phrase «systems therapy which»

My specialty revolves around individual and family systems therapy which includes a unique approach to couples therapy (marriage counseling), life transitions, children, adolesecents and family of origin issues.

Not exact matches

One setback for these therapies which use the body's immune system to fight cancers is that they are, at times, more effective in certain patient pools than others.

The company recently won FDA approval for its MRIdian Linac system, which is a product that marries radiation therapy and magnetic resonance imaging (MRI) together.

For example, we've seen new discoveries in health care recently, especially in immuno - oncology therapies, which help the immune systems of cancer patients recognize and destroy cancerous cells.

Frank Riessman, The Culturally Deprived Child [New York: Harper, 1962]-RRB- This is why middle - class talk therapies are inadequate and why the poor may not do well in middle - class - oriented school systems which emphasize verbal skills, abstract reasoning, and knowledge for knowledge's sake.

One such area which illustrates this point is family systems therapy.

The working concepts and methods of the systemic therapies may well give us resources for fostering the continuing self - renewal which is needed within our people - serving institutions and wider systems.

It follows from this understanding of the counselor that the value system which he holds is not a matter of indifference in therapy.

Featuring clinically proven sounds from world renowned doctors and the world's finest authentic nature sounds, the S - 665 Sound Oasis Sleep Sound Therapy System: Creates a familiar sound environment for your baby Blocks out irritating noises Helps circumvent tinnitus discomfort Creates a soothing atmosphere so you and your family can: Fall asleep easier Get higher quality sleep Enhance concentration Feel more alert and comfortable throughout the day The S - 665 sleep machine incorporates the world's only «sound card» technology which enables you to change sound themes by simply inserting a new memory card containing 12 different sounds.

Featuring clinically proven sounds from world renowned doctors and the world's finest authentic nature sounds, the S - 660 Sound Oasis Sleep Sound Therapy System: Blocks out irritating noises Helps circumvent tinnitus discomfort Creates a soothing atmosphere so you: Fall asleep easier Get higher quality sleep Enhance concentration Feel more alert and comfortable throughout the day The S - 660 sleep machine incorporates the world's only «sound card» technology which enables you to change sound themes by simply inserting a new memory card containing 12 different sounds.

«If we know which genes are damaged in a breast cancer patient's immune system, prevention or even therapy can be tailored by giving vaccines or perhaps antiviral drugs to reduce the chances of recurrence,» said Friedenson.

And early stage startup Neochromosome, which includes Boeke, intends to raise money to design synthetic chromosomes for medicine that could be used in an off - the - shelf universal cell line in cell therapies and transplants with minimal risk of rejection from the immune system.

Their findings suggest that therapies based on these compounds could help to treat rheumatoid arthritis, which occurs when the immune system attacks the joints, causing pain and swelling.

So he joined GSK Vaccines in 2010, as a molecular biologist in the company's Antigen - Specific Cancer Immunotherapeutic program, which aims to harness the immune system for the development of well - tolerated cancer therapies.

Treatment with an investigational CAR T - cell therapy induced complete remission of a brain metastasis of the difficult - to - treat tumor diffuse large - B - cell lymphoma (DLBCL), which had become resistant to chemotherapy — the first report of a response to CAR T - cells in a central nervous system lymphoma.

The ability of these children to maintain an intact immune system in the face of ongoing viral replication and in the absence of antiretroviral therapy can provide us with new insights into hitherto unknown defense mechanisms, which could eventually benefit other HIV patients,» says Professor Oliver T. Keppler, Chair of Virology at the Pettenkofer Institute, and former head of the German Reference Center for Retroviruses in Frankfurt am Main.

«The treatment of multiple myeloma has improved significantly in recent years with the introduction of therapies such as proteasome inhibitors [which interfere with tumor cells» protein - disposal system] and potent immuno - modulatory agents,» said the paper's senior author and lead investigator, Paul Richardson, MD, clinical program leader and director of clinical research at Dana - Farber's Jerome Lipper Multiple Myeloma Center, and the R.J. Corman professor at Harvard Medical School.

«First, it would allow us to understand what DUX4 does in muscle to cause muscle loss, and second, it would provide a system in which efficacy of potential therapies could be evaluated before they are tested in humans.»

There are experiments in using stock market — like systems, in which people bet on ideas to answer seemingly unanswerable questions, like when terrorist events will occur or when stem cell therapy will allow a person to grow new teeth.

Unlike traditional mask based therapies — which have been shown to work only in some patients under certain conditions in CSA — the remede ® system is acceptable to patients and improves their sleep and heart function.»

The answer to increasing the effectiveness of immune therapies, or perhaps at least to choosing which patients are most likely to benefit from immune therapies, may lie in understanding the ways viruses (and cancers themselves) have evolved to evade the immune system.

And, in fact, these doctors and researchers are finding incredible success with this strategy; for example, PD - 1 inhibitors remove this «cloak» that cancers use to hide from the immune system, and CAR - T cell therapies use specially engineered T - cells to seek cancer - specific proteins and destroy the cancer cells to which they are attached.

The stereotactic ablative radiation therapy (SABR) was used to treat inferior vena cava tumor thrombus (IVC - TT) that reached the heart, a complication of kidney cancer in which the tumor extends into the venous system − the system of veins that return blood to the heart.

Raydiance's technology has attracted the attention of the U.S. Food and Drug Administration (FDA), which in July 2007 signed the company to a two - year cooperative research and development agreement that has allowed the FDA's Center for Devices and Radiological Health (CDRH) to evaluate the use, safety and effectiveness of Raydiance's USP laser system in a number of areas, including the ablation of corneal tissues in refractive surgery and corneal repair; the administration of light therapy for treating cancer, cardiovascular disease and diabetes; and the removal of plaque on teeth without damaging the enamel.

The costs of drug therapy were analysed as overall costs, and the costs of hospital days were calculated according to the Finnish health care system's unit costs, which also include the patient's payment contribution.

Instead, we administer a combination therapy to allow immune cells, which are capable of killing tumors, to see tumors that were previously invisible to the immune system.»

The researchers designed the oral delivery system, which contains micro - and nanoparticles, to carry a protein therapy that treats hemophilia B.

Using this system upon request from a patient, it has become possible to treat the patient ineligible for a heart transplant or destination therapy and use this technique for tunneling the internal power cable through the neck to the head, which is approved overseas, but not in Japan.

They currently have a trial under way at the U-M Health System which tests a two - part gene therapy approach in patients with brain tumors called gliomas in an effort to get the immune system to attack the System which tests a two - part gene therapy approach in patients with brain tumors called gliomas in an effort to get the immune system to attack the system to attack the tumor.

But if the immune system is involved in the new - found problems, it provides additional impetus to develop «personalised» therapies, in which neurons are grown from a patient's own cells, and so should be less likely to provoke an immune reaction.

«It combines these with a new and exciting therapy called immunotherapy — a treatment which harnesses the body's immune system to help with fighting cancer.»

The combination could explain why relapse occurs in some patients with therapies targeting CTLA - 4 and PD - 1 checkpoints, which evade the body's immune system.

The new paper «Extinction Reverses Olfactory Fear Conditioned Increases in Neuron Number and Glomerular Size» highlights the results of a first of its kind study in which researchers reveal that the olfactory system in the brain is biologically and structurally more sensitive to trauma cues than previously thought, and that it's possible for fear behaviors associated with emotional learning to be reversed through exposure - based talk therapy.

Inclusion Criteria: • Pathologically proven acute myeloid leukemia (AML) or intermediate, high - risk, or very high risk Myelodysplastic Syndrome (MDS) as defined by the World Health Organization (WHO) criteria or Revised International Prognostic Scoring System (IPSS - R) which is relapsed or refractory (R / R) to standard therapy and / or for which standard therapy is contraindicated or which has not adequately responded to standard therapy.

Included among the numerous recipients of Mr. Sanford's gifts, that total more than one billion dollars, are: the Edith Sanford Foundation for Breast Cancer that was created in 2012 by a gift of $ 100 million in honor of Mr. Sanford's mother who died of breast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Medicine.

This novel approach, which reveals complex interactions between cells and proteins, can also be used for other diseases to generate new knowledge about the regulation and dysregulation of the immune system, which can eventually give rise to new, improved immunological therapies.

This new therapy works well against B - cell acute lymphomblastic leukemia, a cancer of the blood system, which has led the U.S. Food and Drug Administration to expedite approval of the first CAR - T treatment for children and young adults.

The study highlights an opportunity to combine this form of therapy with cancer immunotherapy drugs such as checkpoint inhibitors, which unleash the immune system's full cancer - fighting power, the researchers say.

Because they stimulate the immune system rather than introducing an agent or process that can kill healthy cells along with the malignant ones, these therapies — which include commonly prescribed treatments such as trastuzumab (Herceptin), pembrolizumab (Keytruda) and nivolumab (Opdivo)-- have been noteworthy not only for their effectiveness but for their tolerability.

«Having a very efficient and practical way of generating patient - specific stem cells, which unlike human embryonic stem cells, wouldn't be rejected by the patient's immune system after transplantation brings us a step closer to the clinical application of stem cell therapy,» says Belmonte, PhD., a professor in the Gene Expression Laboratory and director of the Center of Regenerative Medicine in Barcelona, Spain.

In mouse models in which the endogenous Smn1 gene has been knocked out and human versions of SMN2 have been swapped in, the Isis therapy — a so - called «antisense oligonucleotide» — delivered to the mouse central nervous system (CNS) increased the expression of full - length SMN protein in motor neurons, improved muscle strength in behavioral tests and extended the rodents» median lifespan from 16 days to 26 days3.

The high doses of therapy lead to the destruction of a patient's own marrow and immune system, which is then replaced by marrow from a donor or from peripheral blood stem cells that have been harvested before therapy.

Development of a comprehensive system which can enrich hPSC - CMs will be ultimately useful for cell therapy for diseased hearts, human cardiac disease modeling, cardiac toxicity screening, and cardiac tissue engineering.

In a paper published online Aug. 31, by Nature Medicine, researchers report that using a monoclonal antibody called anti-CD47, which blocks the «don't - eat - me» signal on malignant cells, to treat mice with an intact immune system provides a much more lifelike way to study and develop an immune - based cancer therapy.

Research is already underway at City of Hope to unlock the immune system's role in diabetes, including T cell modulation and stem cell - based therapies that may reverse the autoimmune attack on islet cells in the pancreas, which is the cause of T1D.

It is also the first in an emerging class of therapies called «checkpoint blockade,» which enhance the immune system's ability to attack cancer by interfering with immunological checkpoints that slow or stop immune cell activation and proliferation in the presence of tumors or chronic viral infection.

These findings have identified an alternative source of replacement tissue for use in human retinal cellular therapies, and provide a new in vitro cellular model system in which to study RPE diseases affecting human patients.

Preliminary analyses of the results of the first combination trials, which show higher response rates than with either agent alone, offer some optimism that these locoregional therapies will find application — as treatment for patients who can not tolerate systemic immunotherapies, to alleviate locoregional morbidity, and perhaps even to «prime» the immune system.

The chronic leukemias have very effective treatments in the form of biologic therapies (such as Gleevec for CML), which are designed to stimulate the body's immune system to target cancer cells.

For the uninitiated here is my (poorly informed) explanation of what PRI is: postural restoration is a system of physical therapy which emphasises the role of posture and joint positioning in creating mobility and stability in the relevant segments throughout the body.